Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

PRLog (Press Release) - Nov. 3, 2011 - GlobalData, the industry analysis specialist, has released its new report, “Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Non - Small Cell Lung Cancer (NSCLC) Therapeutics market. The report identifies the key trends shaping and driving the global Non - Small Cell Lung Cancer (NSCLC) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Non - Small Cell Lung Cancer (NSCLC) Therapeutics sector.

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?...

Scope of the report:
Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Non - Small Cell Lung Cancer (NSCLC)Therapeutics market revenues data from 2005 to 2010 and forecast to 2018.
Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
Analysis of the current and future competition in the seven key countries Non - Small Cell Lung Cancer (NSCLC) Therapeutics market.
Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Non - Small Cell Lung Cancer (NSCLC) Therapeutics market.
Analysis of key recent licensing and partnership agreements in Non - Small Cell Lung Cancer (NSCLC) Therapeutics market.

Why you need this report:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global Non - Small Cell Lung Cancer (NSCLC) Therapeutics market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Non - Small Cell Lung Cancer (NSCLC)Therapeutics market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Do follow us at facebook:
http://www.facebook.com/PharmaceuticalsandHealthcareMarke...
Visit our report store: http://www.globalmarketsdirect.com

For more details contact:

pressreleases@globalmarketsdirect.com
North America:    +1 646 395 5477
Europe:        +44 207 753 4299
           +44 1204 543 533
Asia Pacific:       +91 40 6616 6782